SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-15-006520
Filing Date
2015-12-31
Accepted
2015-12-31 17:23:55
Documents
30
Period of Report
2015-05-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 244406
2 ex31-1.htm EX-31.1 13875
3 ex32-1.htm EX-32.1 7325
  Complete submission text file 0001493152-15-006520.txt   974846

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE ptlf-20150531.xml EX-101.INS 86104
5 XBRL SCHEMA FILE ptlf-20150531.xsd EX-101.SCH 11441
6 XBRL CALCULATION FILE ptlf-20150531_cal.xml EX-101.CAL 19351
7 XBRL DEFINITION FILE ptlf-20150531_def.xml EX-101.DEF 23926
8 XBRL LABEL FILE ptlf-20150531_lab.xml EX-101.LAB 90955
9 XBRL PRESENTATION FILE ptlf-20150531_pre.xml EX-101.PRE 65302
Mailing Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210
Business Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210 (310) 279-5152
PetLife Pharmaceuticals, Inc. (Filer) CIK: 0001354591 (see all company filings)

IRS No.: 331133537 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52445 | Film No.: 151316233
SIC: 2860 Industrial Organic Chemicals